MRE11 and neoplasm: In another study of MRN expression in breast cancers, the authors reported reduced RAD50 (3%), MRE11 (7%) and NBS1 (10%) protein expression, particularly in triple-negative disease, high-grade tumours and in familial breast cancers23.